Scinai’s Aerosolized NanoAbs: Promising COVID-19 Prophylactic and Therapeutic

Scinai’s Aerosolized NanoAbs: Promising COVID-19 Prophylactic and Therapeutic, Study Finds

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products, has announced the publication…

Read More »